Effects of obesity on substrate utilization during exercise. 2002

Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

OBJECTIVE The capacity for lipid and carbohydrate (CHO) oxidation during exercise is important for energy partitioning and storage. This study examined the effects of obesity on lipid and CHO oxidation during exercise. METHODS Seven obese and seven lean [body mass index (BMI), 33 +/- 0.8 and 23.7 +/- 1.2 kg/m(2), respectively] sedentary, middle-aged men matched for aerobic capacity performed 60 minutes of cycle exercise at similar relative (50% VO(2max)) and absolute exercise intensities. RESULTS Obese men derived a greater proportion of their energy from fatty-acid oxidation than lean men (43 +/- 5% 31 +/- 2%; p = 0.02). Plasma fatty-acid oxidation determined from recovery of infused [0.15 micromol/kg fat-free mass (FFM) per minute] [1-(13)C]-palmitate in breath CO(2) was similar for obese and lean men (8.4 +/- 1.1 and 29 +/- 15 micromol/kg FFM per minute). Nonplasma fatty-acid oxidation, presumably, from intramuscular sources, was 50% higher in obese men than in lean men (10.0 +/- 0.6 versus 6.6 +/- 0.8 micromol/kg FFM per minute; p < 0.05). Systemic glucose disposal was similar in lean and obese groups (33 +/- 8 and 29 +/- 15 micromol/kg FFM per minute). However, the estimated rate of glycogen-oxidation was 50% lower in obese than in lean men (61 +/- 12 versus 90 +/- 6 micromol/kg FFM per minute; p < 0.05). CONCLUSIONS During moderate exercise, obese sedentary men have increased rates of fatty-acid oxidation from nonplasma sources and reduced rates of CHO oxidation, particularly muscle glycogen, compared with lean sedentary men.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon

Related Publications

Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
January 2008, International journal of sports medicine,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
August 2011, Pediatric exercise science,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
September 2004, Journal of applied physiology (Bethesda, Md. : 1985),
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
January 1977, Annals of the New York Academy of Sciences,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
January 1972, Scandinavian journal of clinical and laboratory investigation,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
November 1977, Scandinavian journal of clinical and laboratory investigation,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
August 1986, Journal of applied physiology (Bethesda, Md. : 1985),
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
April 1995, The American journal of clinical nutrition,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
December 2005, International journal of sport nutrition and exercise metabolism,
Bret H Goodpaster, and Robert R Wolfe, and David E Kelley
February 2003, Diabetes & metabolism,
Copied contents to your clipboard!